356 / 1161
Simultaneously integrated boost (SIB)
Results SIB tumor bed (stage I-III breast cancer patients):
- Excellent 5-year control (99%)
Bantema-Joppe RO 2013
- Higher dose per fraction to tumor bed
→
Equal toxicity and cosmetic result
Bantema-Joppe IJROBP 2012